In fact, CDKN1B, also known as cyclin‐dependent kinase inhibitor 1B, acts as a critical regulator of cell cycle progression, primarily functioning as a tumor suppressor by inhibiting cyclin‐dependent kinases (CDKs) and arresting cells in the G1 phase. The gene discussed is CDKN1B; the disease is neoplasm.